Research
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
-
* Corresponding author: Gail L Brown gbrown@telik.com
Journal of Hematology & Oncology 2010, 3:9 doi:10.1186/1756-8722-3-9
No comments have yet been made on this article.